Guselkumab in the treatment of severe hidradenitis suppurativa
2018; Wiley; Volume: 33; Issue: 3 Linguagem: Inglês
10.1111/jdv.15368
ISSN1468-3083
AutoresMaximilian Kovács, Maurizio Podda,
Tópico(s)Chemotherapy-related skin toxicity
ResumoJournal of the European Academy of Dermatology and VenereologyVolume 33, Issue 3 p. e140-e141 Letter to the Editor Guselkumab in the treatment of severe hidradenitis suppurativa M. Kovacs, Corresponding Author M. Kovacs maximilian.kovacs@mail.klinikum-darmstadt.de orcid.org/0000-0002-2964-7145 Klinikum Darmstadt GmbH, Darmstadt, GermanyCorrespondence: M. Kovacs. E-mail: maximilian.kovacs@mail.klinikum-darmstadt.deSearch for more papers by this authorM. Podda, M. Podda Klinikum Darmstadt GmbH, Darmstadt, Germany Goethe University Frankfurt am Main, Frankfurt, GermanySearch for more papers by this author M. Kovacs, Corresponding Author M. Kovacs maximilian.kovacs@mail.klinikum-darmstadt.de orcid.org/0000-0002-2964-7145 Klinikum Darmstadt GmbH, Darmstadt, GermanyCorrespondence: M. Kovacs. E-mail: maximilian.kovacs@mail.klinikum-darmstadt.deSearch for more papers by this authorM. Podda, M. Podda Klinikum Darmstadt GmbH, Darmstadt, Germany Goethe University Frankfurt am Main, Frankfurt, GermanySearch for more papers by this author First published: 27 November 2018 https://doi.org/10.1111/jdv.15368Citations: 26Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume33, Issue3March 2019Pages e140-e141 RelatedInformation
Referência(s)